Literature DB >> 11386205

Prevalence of sleepiness and its relation to autonomic evidence of arousals and increased inspiratory effort in a community based population of men and women.

J R Stradling1, C Barbour, J Glennon, B A Langford, J H Crosby.   

Abstract

Degrees of sleep apnoea and daytime sleepiness are quite common in community populations. However the relationship between the two is poor, although sleepiness does correlate better with a history of snoring. It has been suggested that sleep can be fragmented by upper airways obstructive events, short of full apnoeas or hypopnoeas, and that these events may not provoke full cortical arousal, but be detectable through activation of the autonomic system. Failure to detect both these could mask a relationship between 'sleep apnoea' and daytime sleepiness. We have therefore measured sleepiness (Epworth Sleepiness Scale) in addition to both autonomic 'arousals' and inspiratory effort (using pulse transit time) in 473 men and women at home. Although sleepiness was related to a history of snoring, it was not significantly predicted by the measures of autonomic 'arousal', or inspiratory effort. Reported snoring and objectively measured snoring correlated poorly. As in other studies, nocturnal hypoxic dips were correlated with obesity, age, alcohol consumption, drug usage and a history of snoring. These data make it unlikely that sleep fragmentation from subtle variants of sleep apnoea and 'autonomic' (or 'subcortical') arousals are an important source of daytime sleepiness in the community.

Entities:  

Mesh:

Year:  2000        PMID: 11386205     DOI: 10.1046/j.1365-2869.2000.00218.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  18 in total

1.  Can mandibular advancement devices be a satisfactory substitute for short term use in patients on nasal continuous positive airway pressure?

Authors:  D M Smith; J R Stradling
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

2.  Sleep disturbances in adult survivors of childhood brain tumors.

Authors:  Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

3.  Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.

Authors:  G V Robinson; J C T Pepperell; H C Segal; R J O Davies; J R Stradling
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

Review 4.  Sleep . 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome.

Authors:  D Schlosshan; M W Elliott
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

5.  An ECG-based algorithm for the automatic identification of autonomic activations associated with cortical arousal.

Authors:  Mathias Basner; Barbara Griefahn; Uwe Müller; Gernot Plath; Alexander Samel
Journal:  Sleep       Date:  2007-10       Impact factor: 5.849

6.  Improving the utility of interpreting sleep fragmentation.

Authors:  Edward J Stepanski
Journal:  J Clin Sleep Med       Date:  2007-04-15       Impact factor: 4.062

Review 7.  Approaches to the assessment of arousals and sleep disturbance in children.

Authors:  Shalini Paruthi; Ronald D Chervin
Journal:  Sleep Med       Date:  2010-08       Impact factor: 3.492

8.  Obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  Mohammed A Al-Abri; Khamis M Al-Hashmi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

Review 9.  Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.

Authors:  Karl A Franklin; Eva Lindberg
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Sleep stage dynamics differ between children with and without obstructive sleep apnea.

Authors:  Ronald D Chervin; Judith L Fetterolf; Deborah L Ruzicka; Brian J Thelen; Joseph W Burns
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.